Toxoplasmosis Frequency Rate in Rheumatoid Arthritis Pa-tients in Northeastern Iran

1. Hill D, Dubey J. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect. 2002; 8(10):634-40.
2. Tian AL, Gu YL, Zhou N, et al. Seroprevalence of Toxoplasma gondii infection in arthritis patients in eastern China. Infect Dis Poverty. 2017; 6(1):153.
3. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Eng J Med. 2011; 365(23):2205-19.
4. Listing J, Gerhold K, Zink A. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment. Rheumatology(Oxford). 2013; 52(1):53-61.
5. Germano V, Cattaruzza MS, Osborn J, et al. Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-α antagonists. J Transl Med. 2014; 12(1):77.
6. Shapira Y, Agmon-Levin N, Selmi C, et al. Prevalence of anti-Toxoplasma antibodies in patients with autoimmune diseases. J Autoimmun. 2012; 39(1-2):112-6.

7. Donahoe SL, Phalen DN, McAllan BM, et al. Differential gamma interferon-and tumor necrosis factor alpha-driven cytokine response distinguishes acute infection of a metatherian host with Toxoplasma gondii and Neospora caninum. Infect Immun. 2017; 85(6):e00173-17.
8. Derouich‐Guergour D, Aldebert D, Vigan I, et al. Toxoplasma gondii infection can regulate the expression of tumour necorsis factor‐α receptors on human cell in vitro. Parasite Immunol. 2002; 24(5):271-9.
9. Moudgil KD, Choubey D. Cytokines in autoimmunity: role in induction, regulation, and treatment. Journal Interferon Cytokine Res. 2011; 31(10):695-703.
10. Schulze-Koops H, Kalden JR. The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2001; 15(5):677-91.
11. Mordue DG, Monroy F, La Regina M, et al. Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J Immunol. 2001; 167(8):4574-84.
12. Hosseininejad Z, Sharif M, Sarvi S, et al. Toxoplasmosis seroprevalence in rheumatoid arthritis patients: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2018; 12(6):e0006545.
13. Bas S, Genevay S, Meyer O, et al. Anti‐cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology. 2003; 42(5):677-80.
14. Wu JF, Yang YH, Wang LC, et al. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in juvenile rheumatoid arthritis. Clin Exp Rheumatol. 2007; 25(5):782.
15. Fischer S, Agmon-Levin N, Shapira Y, et al. Toxoplasma gondii: bystander or cofactor in rheumatoid arthritis. Immunol Res. 2013; 56(2-3):287-92.
16. Bouratbine A, Siala E, Chahed M, et al. Sero-epidemiologic profile of toxoplasmosis in northern Tunisia. Parasite (Paris, France). 2001; 8(1):61-6.
17. El-Sayed NM, Kishik SM, Fawzy RM. The current status of Toxoplasma gondii infection among Egyptian rheumatoid arthritis patients. Asian Pac J Trop Dis. 2016; 6(10):797-801.
18. Masoori L, Rezaei N, Molazadeh M, Alizadeh S, Hassanpour H. Development of rheumatoid arthritis by toxoplasmosis in Iranian patients. J Kerman Univ Medical Sci. 2021.
19. Wilking H, Thamm M, Stark K, et al. Prevalence, incidence estimations, and risk factors of Toxoplasma gondii infection in Germany: a representative, cross-sectional, serological study. Sci Rep. 2016; 6:22551.
20. Chiang T-Y, Kuo M-C, Chen C-H, et al. Risk factors for acute Toxoplasma gondii diseases in Taiwan: a population-based case-control study. PLoS One. 2014; 9(3).
21. Ali T, Sindhu Kaitha SM, Ftesi A, et al. Clinical use of anti-TNF therapy and increased risk of infections. Drug, Healthc Patient Saf. 2013; 5:79.
22. Gaffen SL. The role of interleukin-17 in the pathogenesis of rheumatoid arthritis. Curr Rheumatol Rep. 2009; 11(5):365.
23. Li Y-X, Xin H, Zhang X-Y, et al. Toxoplasma gondii infection in diabetes mellitus patients in China: Seroprevalence, risk factors, and case-control studies. Biomed Res Int. 2018; 2018.
24. Kaňková Š, Prochazkova L, Flegr J, et al. Effects of latent toxoplasmosis on autoimmune thyroid diseases in pregnancy. PloS One. 2014; 9(10).
25. Oruç S, Karakaya F, Demirbas H, Çeçen İ, Küsbeci ÖY, Yaman M, Miman Ö. Relationship of Toxoplasma Gondii Exposure with Multiple Sclerosis. Eur J Gen Med. 2016; 13(1).
26. Asgari Q, Motazedian MH, Khazanchin A, Mehrabani D, Naderi Shahabadi S. High Prevalence of Toxoplasma gondii Infection in Type I Diabetic Patients. J Parasitol Res. 2021; 2021.

留言 (0)

沒有登入
gif